Colon CancerPhase 2/3NCT04167436
Fit for Surgery. Multimodal Prehabilitation in Colorectal Cancer Patients
A Phase 2/3 study testing Prehabilitation in people with Colon Cancer and Rectal Cancer, run by Zealand University Hospital at 2 sites in Denmark.
Trial summary
Randomized clinical trial of multimodal prehabilitation in vulnerable patients with colon or rectal cancer prior to surgery. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Colon Cancer, Rectal Cancer, Frailty
- What is being tested?
- Prehabilitation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 48 participants
- Where
- 2 sitesDenmark
- Study dates
- 1 May 2019to 1 Aug 2022
- Phase
- Phase 2/3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Undergoing elective colorectal cancer surgery
- WHO performance status I and II
- Signed consent
Who cannot join
- Known metastatic disease
- Unable to perform baseline test or basic training e.g. paralytic or completely immobilized patients, orthopedic impairments.
- ASA 4 or 5 (American Society of Anesthesiologist Classification)
- Neoadjuvant chemo- or radiation therapy
- Renal failure III B or higher
- Illiteracy or unable to write or understand Danish
- Cognitive disabilities, which affects adherence e.g. severe dementia (MMSE score ≤17).
- Withdrawal of consent.
Trial locations and contacts
2 sites in 1 country.
Denmark2 sites, 2 recruiting
- Recruiting
Zealand University Hospital
Køge, Danmark, 4600
Rasmus D Bojesen, MD, 26193789, rasmus.bojesen@gmail.com
- Recruiting
Slagelse Hospital
Slagelse, Danmark, 4200
Rasmus D Bojesen, MD, 26193789, rasmus.bojesen@gmail.com
About this study
Official title: Fit for Surgery. Clinical Randomized Trial of Multimodal Prehabilitation Strategy in Patients With Colorectal Cancer.
Randomized clinical trial of multimodal prehabilitation in vulnerable patients with colon or rectal cancer prior to surgery.
Read the detailed description
Fit for surgery is a randomized clinical trial of multimodal prehabilitation prior to colon or rectal cancer surgery. Participants will either receive
The study is a part of the PREHAB study which is performed in collaboration with international centers.
The full protocol are published BMC Cancer. 2019 Jan 22;19(1):98. doi: 10.1186/s12885-018-5232-6.
- Conditions
- Colon Cancer, Rectal Cancer, Frailty
- Being tested
- Prehabilitation
- Keywords
- Prehabilitation, Colon cancer, WHO performance status, Rectal cancer, Exercise, Nutritional supplement
- Medical subject headings
- Colonic Neoplasms, Rectal Neoplasms, Frailty, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PrehabilitationOther
A minimum of four weeks of prehabilitation with exercise three times a week, protein and vitamin supplements, dietitian consultation and medical optimization prior to surgery.
| Study group | Role | What they receive |
|---|---|---|
| Prehabilitation | Experimental | Patients receive multi-modal prehabilitation with exercise three times weekly, protein supplements, vitamin supplements, dietitian consultation and medical optimization prior to surgery. A minimum of four weeks. Receives: Other: Prehabilitation |
| Standard of Care | No intervention | Receives standard of care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Quality of Recovery 15
Difference in postoperative recovery between baseline and within 3 days after surgery. The cumulative score ranges from 0-150, with a higher value indicating a better outcome
Measured: 3 days after surgery
Changes in physical fitness prior to surgery
Changes in VO2 max between baseline and prior to surgery
Measured: Baseline, prior to surgery and 30 days after surgery
Complications
Complications measured by the comprehensive complication index. The score ranges from 0-100 with with a higher value indicating a worse outcome.
Measured: 30 days after surgery
Changes in immunological function
Changes in immunological function measured by nanostring in blood and tumor (in the invasive front)
Measured: Blood work taken at baseline, prior to surgery, three days after surgery and four weeks after surgery. Tumor from resectionspecimen
Secondary outcomes (12)
Disease specific quality of life - EORTC c30
European Organisation for Research and Treatment of Cancer Questionaire c 30 (EORTC c30). The EORTC c30 contains 6 domains which will each be assessed for mean changes in their cumulative score. The domains are physical function, role function, emotional function, pain, fatigue and global health. A higher value indicating a worse outcome
Measured: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Disease specfic quality of life - EORTC c29
European Organisation for Research and Treatment of Cancer Questionaire c 29 (EORTC). The questionnaire contains 29 items, with a 4 point Likert scale for symptoms and 7 point Likert scale for quality of life and global health. For the 4 point Likert scale the higher the score the worse the outcome. For the 7 point likert scale higher values indicating a better outcome. Analysis will be performed for changes in individual symptoms and cumulative aggregation of scores will not be performed.
Measured: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Overall quality of life - SF-36
Short Form 36 question (SF-36) health questionnaire. The questionnaire contains eight domains: physical functioning, pain, limitations due to physical health problems, limitations due to personal or emotional problems, emotional well-being, social functioning, fatigue, and general health perceptions. Scores for each domain range from 0 to 100 and the analysis will be performed as mean difference between baseline and the following time frame. A higher value indicating a better outcome.
Measured: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Psychological health - Depression - PHQ-9
Patient Health Questionnaire 9 (PHQ-9) Depression test. The PHQ-9 have a maximum of 27 points and a minimum of 0. The outcome is point change between baseline and following time frame. A higher value indicating a worse outcome
Measured: the day prior to surgery,30 days after surgery, 60 days after surgery and one year after surgery
Psychological health - General anxiety - GAD-7
General Anxiety Disorder 7-item (GAD-7). The questionnaire have a maximum of 21 points and a minium of 0. The outcome is the point change between baselin and the following time frame. A higher value indicating a worse outcome
Measured: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Physical function (6-MWT)
6-Minutes walk test. Measures how far the participant can walk in 6 minutes measured in meters
Measured: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Physical function (STS)
Sit-to-stand test. Test of how many times the patient can rise from a chair in 30 seconds.
Measured: The day prior to surgery, 30 days after surgery, and 60 days after surgery.
Physical function (Stair climb test)
Stair climb test will be measured as the number of steps (17 mc in height) the paitent can rise in 30 secounds.
Measured: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Physical function (Leg extension test)
Leg extension test will be measured by fixed dynaometer in newtons three times on each leg and the maximum for each leg used for analysis.
Measured: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Physical function (Hand grip strength)
Hand grip strength measured by hand-held dynanometer in kilograms. Measured 3 times on each hand and will use the maximum obtained.
Measured: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Nutritional status
Increase/decrease in total body weight in percent.
Measured: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Remission and cancer free survival
Remission and cancer free survival
Measured: 5 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Nov 2019
- Study start1 May 2019
- Primary completion1 May 2022 (estimated)
- Study completion1 Aug 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Colon CancerStudies of the same condition, open and under way.
- More trials run by Zealand University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2/3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized Clinical Trial with an intervention arm and a standard of care arm.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 48 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Zealand University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04167436
- Sponsor's protocol ID
- REG-040-2017
- Status last verified
- Feb 2022
- First submitted
- 11 Nov 2019
- Last updated
- 3 Mar 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Bojesen RD, Dalton SO, Skou ST, Jorgensen LB, Walker LR, Eriksen JR, Grube C, Justesen TF, Johansen C, Slooter G, Carli F, Gogenur I. Preoperative multimodal prehabilitation before elective colorectal cancer surgery in patients with WHO performance status I or II: randomized clinical trial. BJS Open. 2023 Nov 1;7(6):zrad134. doi: 10.1093/bjsopen/zrad134.
PubMed 38060453Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2023 May 10;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub3.
PubMed 37162250Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2022 May 19;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub2.
PubMed 35588252Bojesen RD, Jorgensen LB, Grube C, Skou ST, Johansen C, Dalton SO, Gogenur I. Fit for Surgery-feasibility of short-course multimodal individualized prehabilitation in high-risk frail colon cancer patients prior to surgery. Pilot Feasibility Stud. 2022 Jan 21;8(1):11. doi: 10.1186/s40814-022-00967-8.
PubMed 35063042
Study at a glance
From the registry record, last updated by the sponsor on 3 Mar 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Fit for Surgery. Clinical Randomized Trial of Multimodal Prehabilitation Strategy in Patients With Colorectal Cancer.
- ClinicalTrials.gov ID
- NCT04167436
- Acronym / sponsor ID
- REG-040-2017
- Conditions
- Colon Cancer, Rectal Cancer, Frailty
- Keywords
- Prehabilitation, Colon cancer, WHO performance status, Rectal cancer, Exercise, Nutritional supplement
- Phase
- Phase 2/3
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 48 participants (estimated)
- Lead sponsor
- Zealand University HospitalUniversity, hospital or other
- Study start
- 1 May 2019 (actual)
- Primary completion
- 1 May 2022 (estimated)
- Study completion
- 1 Aug 2022 (estimated)
- First posted
- 18 Nov 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Randomized clinical trial of multimodal prehabilitation in vulnerable patients with colon or rectal cancer prior to surgery.
Detailed description
Fit for surgery is a randomized clinical trial of multimodal prehabilitation prior to colon or rectal cancer surgery. Participants will either receive
The study is a part of the PREHAB study which is performed in collaboration with international centers.
The full protocol are published BMC Cancer. 2019 Jan 22;19(1):98. doi: 10.1186/s12885-018-5232-6.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Randomized Clinical Trial with an intervention arm and a standard of care arm.
| Arm | Type | Receives |
|---|---|---|
| Prehabilitation | Experimental | Other: PrehabilitationPatients receive multi-modal prehabilitation with exercise three times weekly, protein supplements, vitamin supplements, dietitian consultation and medical optimization prior to surgery. A minimum of four weeks. |
| Standard of Care | No intervention | –Receives standard of care |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Undergoing elective colorectal cancer surgery
- WHO performance status I and II
- Signed consent
Key exclusion criteria (8 listed)
- Known metastatic disease
- Unable to perform baseline test or basic training e.g. paralytic or completely immobilized patients, orthopedic impairments.
- ASA 4 or 5 (American Society of Anesthesiologist Classification)
- Neoadjuvant chemo- or radiation therapy
- Renal failure III B or higher
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PrehabilitationA minimum of four weeks of prehabilitation with exercise three times a week, protein and vitamin supplements, dietitian consultation and medical optimization prior to surgery. | Other | Prehabilitation |
Primary outcome
Quality of Recovery 15
Time frame: 3 days after surgery
Difference in postoperative recovery between baseline and within 3 days after surgery. The cumulative score ranges from 0-150, with a higher value indicating a better outcome
Changes in physical fitness prior to surgery
Time frame: Baseline, prior to surgery and 30 days after surgery
Changes in VO2 max between baseline and prior to surgery
Complications
Time frame: 30 days after surgery
Complications measured by the comprehensive complication index. The score ranges from 0-100 with with a higher value indicating a worse outcome.
Changes in immunological function
Time frame: Blood work taken at baseline, prior to surgery, three days after surgery and four weeks after surgery. Tumor from resectionspecimen
Changes in immunological function measured by nanostring in blood and tumor (in the invasive front)
12 secondary outcomes
Disease specific quality of life - EORTC c30
Time frame: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Disease specfic quality of life - EORTC c29
Time frame: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Overall quality of life - SF-36
Time frame: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Psychological health - Depression - PHQ-9
Time frame: the day prior to surgery,30 days after surgery, 60 days after surgery and one year after surgery
Psychological health - General anxiety - GAD-7
Time frame: the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery
Physical function (6-MWT)
Time frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Physical function (STS)
Time frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery.
Physical function (Stair climb test)
Time frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Physical function (Leg extension test)
Time frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Physical function (Hand grip strength)
Time frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Nutritional status
Time frame: The day prior to surgery, 30 days after surgery, and 60 days after surgery
Remission and cancer free survival
Time frame: 5 years
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Mar 2022.
- Derived from this study: PubMed 38060453Bojesen RD, Dalton SO, Skou ST, Jorgensen LB, Walker LR, Eriksen JR, Grube C, Justesen TF, Johansen C, Slooter G, Carli F, Gogenur I. Preoperative multimodal prehabilitation before elective colorectal cancer surgery in patients with WHO performance status I or II: randomized clinical trial. BJS Open. 2023 Nov 1;7(6):zrad134. doi: 10.1093/bjsopen/zrad134.
- Derived from this study: PubMed 37162250Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2023 May 10;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub3.
- Derived from this study: PubMed 35588252Molenaar CJ, van Rooijen SJ, Fokkenrood HJ, Roumen RM, Janssen L, Slooter GD. Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery. Cochrane Database Syst Rev. 2022 May 19;5(5):CD013259. doi: 10.1002/14651858.CD013259.pub2.
- Derived from this study: PubMed 35063042Bojesen RD, Jorgensen LB, Grube C, Skou ST, Johansen C, Dalton SO, Gogenur I. Fit for Surgery-feasibility of short-course multimodal individualized prehabilitation in high-risk frail colon cancer patients prior to surgery. Pilot Feasibility Stud. 2022 Jan 21;8(1):11. doi: 10.1186/s40814-022-00967-8.
Related trials for Colon Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Not yet recruitingPhase 2
Alberta Cancer Exercise Dose in Colorectal Cancer
Cancer, Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2/3 study testing Prehabilitation in people with Colon Cancer and Rectal Cancer, run by Zealand University Hospital at 2 sites in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this combined phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quality of Recovery 15 (time frame: 3 days after surgery). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04167436, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2022.